The drug monosodium luminol (GVT) preserves crypt-villus epithelial organization and allows survival of intestinal T cells in mice infected with the ts1 retrovirus

Immunology Letters

Volumn 122, Issue 2, 2009, Pages 150-158

  Scofield, Virginia L ^a   Yan, Mingshan ^a   Kuang, Xianghong ^a   Kim, Soo Jin ^a   Wong, Paul K Y ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

GVT; Intestine; Oxidative stress; Retrovirus

Indexed keywords

ANTIOXIDANT; CASPASE 3; GLUTATHIONE; GVT; KI 67 ANTIGEN; PROTEIN PRECURSOR; SODIUM ALPHA LUMINOL; THYROTROPIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL LOSS; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFECT; DRUG MECHANISM; INTESTINE CRYPT; INTESTINE EPITHELIUM CELL; INTESTINE INFECTION; INTESTINE VILLUS; LAMINA PROPRIA; LYMPHOCYTE COUNT; LYMPHOID CELL; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETROVIRUS INFECTION; SMALL INTESTINE; T LYMPHOCYTE; VIRUS MUTANT;

ANIMALS; ANTIOXIDANTS; CD4-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; CYTOPATHOGENIC EFFECT, VIRAL; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, VIRAL; IMMUNE TOLERANCE; INTESTINES; LEUKEMIA VIRUS, MURINE; LEUKEMIA, EXPERIMENTAL; LUMINOL; MICE; MUTATION; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; RETROVIRIDAE INFECTIONS; RETROVIRIDAE PROTEINS;

EID: 61849111203     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.12.012     Document Type: Article

References (52)

1. Asjo B., Fenyo E.M., and Klein G. Moloney virus (M-MuLV) leukemogenesis: virus spread, antibody production and antigenic expression in neonatally virus-inoculated young mice. Int J Cancer 28 (1981) 65-70
2. Wong P.K., and McCarter J.A. Genetic studies of temperature-sensitive mutants of Moloney-murine leukemia virus. Virology 53 (1973) 319-326
3. Kamps C.A., Lin Y.-C., and Wong P.K.Y. Oligomerization and transport of the envelope protein of Moloney murine leukemia virus-TB and of ts1, a neurovirulent temperature-sensitive mutant of MoMuLV-TB. Virology 184 (1991) 687-694
4. env, and neurovirulence of ts1, a mutant of Moloney murine leukemia virus TB. J Virol 64 (1990) 467-475
5. Wong P.K., Szurek P.F., Floyd E., Saha K., and Brooks B.R. Alteration from T- to B-cell tropism reduces thymic atrophy and cytocidal effects in thymocytes but not neurovirulence induced by ts1, a mutant of Moloney murine leukemia virus TB. Proc Natl Acad Sci USA 88 (1991) 8991-8995
6. Wong P.K., Prasad G., Hansen J., and Yuen P.H. ts1, a mutant of Moloney murine leukemia virus-TB, causes both immunodeficiency and neurologic disorders in BALB/c mice. Virology 170 (1989) 450-459
7. Kim H.T., Qiang W., Wong P.K., and Stoica G. Enhanced proteolysis of IκBα and IκBβ proteins in astrocytes by Moloney murine leukemia virus (MoMuLV)-ts1 infection: a potential mechanism of NF-κB activation. J Neurovirol 7 (2001) 466-475
8. Jiang Y., Scofield V.L., Yan M., Qiang W., Liu N., Reid A.J., et al. Retrovirus-induced oxidative stress with neuroimmunodegeneration is suppressed by antioxidant treatment with a refined monosodium a-luminol (Galavit). J Virol 80 (2006) 4557-4569
9. Kim H.T., Tasca S., Qiang W., Wong P.K., and Stoica G. Induction of p53 accumulation by Moloney murine leukemia virus-ts1 infection in astrocytes via activation of extracellular signal-regulated kinases 1/2. Lab Invest 82 (2002) 693-702
10. Kim H.T., Waters K., Stoica G., Qiang W., Liu N., Scofield V.L., et al. Activation of endoplasmic reticulum stress signaling pathway is associated with neuronal degeneration in MoMuLV-ts1-induced spongiform encephalomyelopathy. Lab Invest 84 (2004) 816-827
11. Kim H.T., Qiang W., Liu N., Scofield V.L., Wong P.K., and Stoica G. Up-regulation of astrocyte cyclooxygenase-2, CCAAT/enhancer-binding protein-homology protein, glucose-related protein 78, eukaryotic initiation factor 2α, and c-Jun N-terminal kinase by a neurovirulent murine retrovirus. J Neurovirol 11 (2005) 166-179
12. Liu N., Qiang W., Kuang X., Thuillier P., Lynn W.S., and Wong P.K. The peroxisome proliferator phenylbutyric acid (PBA) protects astrocytes from ts1 MoMuLV-induced oxidative cell death. J Neurovirol 8 (2002) 318-325
13. Liu N., Kuang X., Kim H.T., Stoica G., Qiang W., Scofield V.L., et al. Possible involvement of both endoplasmic reticulum- and mitochondria-dependent pathways in MoMuLV-ts1-induced apoptosis in astrocytes. J Neurovirol 10 (2004) 189-198
14. Liu N., Scofield V.L., Qiang W., Yan M., Kuang X., and Wong P.K. Interaction between endoplasmic reticulum stress and caspase 8 activation in retrovirus MoMuLV-ts1-infected astrocytes. Virology 348 (2006) 398-405
15. Qiang W., Cahill J.M., Liu J., Kuang X., Liu N., Scofield V.L., et al. Activation of transcription factor Nrf-2 and its downstream targets in response to Moloney murine leukemia virus ts1-induced thiol depletion and oxidative stress in astrocytes. J Virol 78 (2004) 11926-11938
16. Qiang W., Kuang X., Liu J., Liu N., Scofield V., Stoica G., et al. Astrocytes survive chronic infection and cytopathic effects of the ts1 mutant of the retrovirus Moloney murine leukemia virus by upregulation of antioxidant defenses. J Virol 80 (2006) 3273-3284
17. Stoica G., Lungu G., Kim H.T., and Wong P.K.Y. Up-regulation of pro-nerve growth factor, neurotrophin receptor p75, and sortilin is associated with retrovirus-induced spongiform encephalomyelopathy. Brain Res 1208 (2008) 204-216
18. Lungu G.F., Stoica G., and Wong P.K.Y. Down-regulation of Jab1, HIF-1a, and VEGF by Moloney murine leukemia virus-ts1 infection: a possible cause of neurodegeneration. J Neurovirol 14 (2008) 239-251
19. Wong P.K.Y., Lynn W.S., Lin Y.C., Choe W., and Yuen P.H. ts1-MoMuLV: a murine model of neuroimmunodegeneration. In: Wong P.K.Y., and Lynn W.S. (Eds). Neuroimmunodegeneration (1998), Springer, Berlin 75-93
20. Clark S., Duggan J., and Chakraborty J. ts1 and LP-BM5: a comparison of two murine retrovirus models for HIV. Viral Immunol 14 (2001) 95-109
21. Sankaran S., George M.D., Reay E., Guadalupe M., Flamm J., Prindiville T., et al. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol 82 (2008) 538-545
22. + T cells are rapidly eliminated in early SIV infection in vivo. J Virol 74 (2000) 57-64
23. + T cells are profoundly depleted during acute simian-human immunodeficiency virus infection, regardless of viral pathogenicity. J Virol 82 (2008) 6039-6044
24. Howard K.E., and Burkhard M.J. FIV infection induces unique changes in phenotype and cellularity in the medial iliac lymph node and intestinal IEL. AIDS Res Hum Retroviruses 23 (2007) 720-728
25. Scofield V.L., Yan M.S., Kuang X., Kim S.J., Crunk D., and Wong P.K.Y. The drug monosodium luminol (GVT) preserves thymic epithelial cell cytoarchitecture and allows thymocyte survival in mice infected with the T cell-tropic, cytopathic retrovirus ts1. Immunol Lett 122 (2009) 159-169
26. Potten C.S., Martin K., and Kirkwood T.B. Ageing of murine small intestinal stem cells. Novartis Found Symp 235 (2001) 66-79 discussion 79-84, 101-4
27. Barker N., van de Wetering M., and Clevers H. The intestinal stem cell. Genes Dev 22 (2008) 1856-1864
28. van der Flier L.G., and Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol (2008) [Epub ahead of print]
29. Guy-Grand D., Azogui O., Celli S., Darche S., Nussenzweig M.C., Kourilsky P., et al. Extrathymic T cell lymphopoiesis: ontogeny and contribution to gut intraepithelial lymphocytes in athymic and euthymic mice. J Exp Med 197 (2003) 333-341
30. Ishikawa H., Naito T., Iwanaga T., Takahashi-Iwanaga H., Suematsu M., Hibi T., et al. Curriculum vitae of intestinal intraepithelial T cells: their developmental and behavioral characteristics. Immunol Rev 215 (2007) 154-165
31. Klein J.R. Thymus-independent development of gut T cells. Chem Immunol 71 (1998) 88-102
32. Lambolez F., Azogui O., Joret A.M., Garcia C., von Boehmer H., Di Santo J., et al. Characterization of T cell differentiation in the murine gut. J Exp Med 195 (2002) 437-449
33. Podd B.S., Thoits J., Whitley N., Cheng H.Y., Kudla K.L., Taniguchi H., et al. T cells in cryptopatch aggregates share TCR γ variable region junctional sequences with γδ T cells in the small intestinal epithelium of mice. J Immunol 176 (2006) 6532-6542
34. Cheroutre H., and Lambolez F. The thymus chapter in the life of gut-specific intra epithelial lymphocytes. Curr Opin Immunol 20 (2008) 185-191
35. Klug D.B., Carter C., Crouch E., Roop D., Conti C.J., and Richie E.R. Interdependence of cortical thymic epithelial cell differentiation and T-lineage commitment. Proc Natl Acad Sci USA 95 (1998) 11822-11827
36. Wang L., Srinivasan S., Theiss A.L., Merlin D., and Sitaraman S.V. Interleukin-7 induces keratin expression in intestinal cells: potential role of keratin-8 in interleukin-6-induced barrier function alterations. J Biol Chem 282 (2007) 8219-8227
37. Wang J., Whetsell M., and Klein J.R. Local hormone networks and intestinal T cell homeostasis. Science 275 (1997) 1937-1939
38. Scofield V.L., Montufar-Solis D., Cheng E., Estes M.K., and Klein J.R. Intestinal TSH production is localized in crypt enterocytes and in villus 'hotblocks' and is coupled to IL-7 production: evidence for involvement of TSH during acute enteric virus infection. Immunol Lett 99 (2005) 36-44
39. Montufar-Solis D., Garza T., Teng B.B., and Klein J.R. Upregulation of ICOS on CD43+ CD4+ murine small intestinal intraepithelial lymphocytes during acute reovirus infection. Biochem Biophys Res Commun 342 (2006) 782-790
40. Pazos-Moura C.C., Ortiga-Carvalho T.M., and Gaspar de Moura E. The autocrine/paracrine regulation of thyrotropin secretion. Thyroid 13 (2003) 167-175
41. Lindl K.A., and Jordan-Sciutto K.L. Examining the endogenous antioxidant response through immunofluorescent analysis of Nrf2 in tissue. Methods Mol Biol 477 (2008) 229-243
42. Pickett C.P., Nguyen T., and Nioi P. The Nrf2-ARE signaling pathway and its activation by oxidative stress. J Biol Chem (2009) [Epub ahead of print]
43. Moi P., Chan K., Asunis I., Cao A., and Kan Y.W. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the β-globin locus control region. Proc Natl Acad Sci USA 91 (1994) 9926-9930
44. Chen X.L., and Kunsch C. Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases. Curr Pharm Des 10 (2004) 879-891
45. Nguyen T., Yang C.S., and Pickett C.B. The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic Biol Med 37 (2004) 433-441
46. Gharavi N., Haggarty S., and El-Kadi A.O. Chemoprotective and carcinogenic effects of tert-butylhydroquinone and its metabolites. Curr Drug Metab 8 (2007) 1-7
47. Purdom-Dickinson S.E., Sheveleva E.V., Sun H., and Chen Q.M. Translational control of Nrf2 protein in activation of antioxidant response by oxidants. Mol Pharmacol 72 (2007) 1074-1081
48. Walsh J.G., Cullen S.P., Sheridan C., Luthi A.U., Gerner C., and Martin S.J. Executioner caspase-3 and caspase-7 are functionally distinct proteases. Proc Natl Acad Sci USA 105 (2008) 12815-12819
49. Lau A., Villenueve N.F., Sun Z., Wong P.K., and Zhang D.D. Dual roles of Nrf2 in cancer. Pharmacol Res 58 (2008) 262-270
50. Belmonte L., Olmos M., Fanin A., Parodi C., Bare P., Concetti H., et al. The intestinal mucosa as a reservoir of HIV-1 infection after successful HAART. AIDS 21 (2007) 2106-2108
51. Bengmark S., and Jeppson B. Gastrointestinal surface protection and mucosa reconditioning. J Parenter Enteral Nutr 19 (1995) 410-415
52. Schmidt W., Wahschaffe U., Schafer M., Zippel T., Arvand M., Meyerhans A., et al. Rapid increase of mucosal CD4 T cells followed by clearance of intestinal cryptosporidiosis in an AIDS patient receiving highly active antiretroviral therapy. Gastroenterology 120 (2001) 984-987